Stockreport

Galecto Reports Third Quarter 2025 Operating and Financial Results

Galecto, Inc.  (GLTO) 
PDF BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncol [Read more]